Lazard Asset Management
IOVA icon

Lazard Asset Management’s Iovance Biotherapeutics IOVA Stock Holding History

Lazard Asset Management’s Portfolio IOVA Stock Details IOVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-7,744
Closed -$13K – 2063
2025
Q2 		$13K Sell
7,744
-13,946
-64% -$34.7K ﹤0.01% 2150
2025
Q1 		$72K Buy
21,690
+21,625
+33,269% +$112K ﹤0.01% 1905
2024
Q4 		$0 Hold
65
– – ﹤0.01% 2401
2024
Q3 		$0 Sell
65
-161
-71% -$1.52K ﹤0.01% 2358
2024
Q2 		$1K Sell
226
-3,642
-94% -$39K ﹤0.01% 2152
2024
Q1 		$56K Sell
3,868
-2,133
-36% -$24.8K ﹤0.01% 1699
2023
Q4 		$48K Buy
6,001
+2,320
+63% +$12.1K ﹤0.01% 1894
2023
Q3 		$16K Buy
3,681
+146
+4% +$953 ﹤0.01% 2121
2023
Q2 		$24K Buy
3,535
+114
+3% +$816 ﹤0.01% 2068
2023
Q1 		$20K Buy
3,421
+699
+26% +$4.82K ﹤0.01% 2055
2022
Q4 		$17K Sell
2,722
-770
-22% -$6.01K ﹤0.01% 2152
2022
Q3 		$32K Buy
3,492
+18
+0.5% +$208 ﹤0.01% 1968
2022
Q2 		$37K Buy
3,474
+117
+3% +$1.53K ﹤0.01% 1939
2022
Q1 		$55K Buy
3,357
+934
+39% +$14.4K ﹤0.01% 1695
2021
Q4 		$46K Buy
2,423
+425
+21% +$9.36K ﹤0.01% 1777
2021
Q3 		$48K Sell
1,998
-1,008
-34% -$23.8K ﹤0.01% 1699
2021
Q2 		$77K Buy
3,006
+2,945
+4,828% +$76.5K ﹤0.01% 1424
2021
Q1 		$1K Hold
61
– – ﹤0.01% 1826
2020
Q4 		$2K Buy
+61
New +$2.42K ﹤0.01% 1806

Other funds holding IOVA

MFM
MHR Fund Management New York $1.92B AUM 119.57% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ICM
Invenomic Capital Management Boston, Massachusetts $1.67B AUM 1.43% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.91B AUM 12.68% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Lazard Asset Management's IOVA Position: Q3 2025 in Review

Lazard Asset Management sold out of Iovance Biotherapeutics (IOVA) in Q3 2025, closing a stake of 7,744 shares — an estimated $13K sold.

Lazard Asset Management first reported a position in IOVA in Q4 2020 and held it in 19 quarters. The position peaked at $77K in Q2 2021. 253 funds tracked by Wall St. Rank hold IOVA as of Q3 2025.

  • Lazard Asset Management reported no remaining Iovance Biotherapeutics position as of Q3 2025 after selling out during the quarter.
  • Lazard Asset Management sold 7,744 Iovance Biotherapeutics shares in Q3 2025, an estimated $13K.
  • Lazard Asset Management first reported a position in Iovance Biotherapeutics in Q4 2020 and held it in 19 quarters.
  • Lazard Asset Management's Iovance Biotherapeutics position peaked at $77K in Q2 2021.
  • 253 funds tracked by Wall St. Rank held Iovance Biotherapeutics as of Q3 2025.

Based on Lazard Asset Management's 13F filing for Q3 2025, filed 14 Nov 2025.